A meta-analysis of nine observational studies (6 cohort, and 3 case-control), however, showed a trend but not a significant association between metformin and the risk of developing pancreatic cancer [48] , indicating a significant heterogeneity in clinical studies on the relationship between metformin use and pancreatic cancer risk.
1
—
—